Investors monitoring the iipr stock price see catalysts in Q3 earnings due next month. Consensus EPS estimates are trending upward on stronger tenant performance. While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable. The defaults indeed sting, as top tenants like PharmaCann (11.5% of annualized base rent) and Green Thumb (7.7%) highlight concentration risk. But IIPRâs fighting back with a tenant refresh program, re-leasing a 205,000-square-foot Michigan property to Berry Green, and a $270 million investment in IQHQ, a life science REIT, to diversify beyond cannabis.